MPP inks deal with French pharma firm to fight malaria in low-income countries

Malaria remains endemic in 91 countries representing half of the world’s population | Licence is key to allow rapid access to innovation for those who need it most.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Voluntary licensing opens up HIV treatment to 100 countries

6 December 2022 Medicines Patent Pool deals have given 20 million people access to HIV treatment | Full list of sub-licensees.

Big Pharma

WHO lays bare deaths from counterfeit drugs

30 November 2017 The World Health Organization (WHO) has released a study on the public health impact of counterfeit drugs, showing that tens of thousands of children die as a result of the problem every year.

Americas

Bill Gates venture and GE sign malaria licensing deal with Access Bio

13 July 2017 A collaboration between Bill Gates and Intellectual Ventures , in partnership with conglomerate GE, has signed a licensing deal with US diagnostics technology company Access Bio to make and sell tools for “rapidly” identifying asymptomatic malaria.

More features

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

Trump’s march-in rights threat: Why pharma is rethinking collaborations

UK gets new IP minister following cabinet reshuffle

Barnes & Thornburg reveals five new IP leaders

MPP inks deal with French pharma firm to fight malaria in low-income countries

More on this story

Editor's picks

Editor's picks

More features